The podcast argues that the public discourse surrounding AI is currently dominated by polarized hype and profit motives, obscuring the technology's true potential for public good. Experts emphasize that while AI offers transformative benefits in areas like healthcare and agriculture, the current trajectory risks prioritizing corporate profit over human agency and equitable access. To ensure an inclusive future, the discussion must shift from fear or utopia to governance, requiring significant public investment and public institutions to balance private innovation. Policy must therefore guide AI development toward solving common societal problems and ensuring that the benefits are accessible to everyday people, rather than merely maximizing shareholder value.
CFR Fellows' Book Launch Series: The Infinity Machine
English Summary
Sebastian Mallaby's "The Infinity Machine" argues that the development of artificial general intelligence (AGI), exemplified by DeepMind's work, is rapidly transforming the global landscape and intensifying geoeconomic competition. The book draws on extensive interviews to detail Demis Hassabis's journey and the technical breakthroughs driving AI progress, while also exploring the ethical and societal concerns surrounding AGI's potential. This suggests a need for proactive policy frameworks to manage the risks and harness the benefits of advanced AI, particularly regarding workforce adaptation and international cooperation. The work highlights the strategic importance of AI talent and infrastructure for national competitiveness.
Related Entries
-
1.
-
2.
The Brookings analysis suggests that the APEC summit will likely be characterized by 'pantomime diplomacy,' with leaders prioritizing optics over substantive breakthroughs on major issues like trade or AI. While high-level meetings may establish processes—such as AI incident reporting—China is expected to use the temporary truce to intensify regional pressure on U.S. allies. Policymakers should therefore manage expectations for major deliverables and instead focus on strengthening functional, working-level dialogues and diversifying partnerships to build resilient stability.
-
3.
The article argues that Chinese AI companies represent a new class of foreign agent, using sophisticated models to subtly promote the Chinese Communist Party's (CCP) political agenda. This influence is evidenced by Chinese models being legally required to uphold 'Core Socialist Values,' forcing them to filter out criticism and promote state narratives, despite their low cost and high adoption rate among American businesses. Policy-wise, the author recommends that the U.S. should not ban the technology but instead enforce the Foreign Agents Registration Act (FARA), treating these AI models as foreign agents to mandate disclosure and labeling, while simultaneously building an allied AI compact to counter Beijing's influence.
-
4.
The publication argues that anticipated U.S. disengagement necessitates a fundamental restructuring of Europe's defense architecture to counter Russia, making a return to the post-1945 security model unlikely. Three potential models—a more European NATO, an EU-based defense union, or a flexible coalition of willing states—are analyzed, with the conclusion that the future will likely be a combination of all three. For Europe to successfully deter aggression, policymakers must treat these frameworks as complementary, focusing urgently on closing the conventional capability gap through increased defense spending and industrial expansion. This shift requires European states to assume primary responsibility for their own security, even while maintaining the U.S. nuclear guarantee.
-
5.
China has established structural dominance over critical pharmaceutical supply chains, making the US and Europe dangerously dependent on Chinese inputs like APIs and KSMs, a dependence Beijing has proven willing to weaponize. To mitigate this security risk, the report argues that a coordinated transatlantic response is essential, moving beyond uncoordinated protectionism. Policy recommendations center on strengthening allied resilience through mutual regulatory recognition, establishing joint strategic stockpiles, and co-financing alternative manufacturing capacity in allied nations. Ultimately, reducing dependence requires sustained US-EU cooperation to build diversified, non-Chinese supply chains for essential medicines.